News | September 03, 2023
BioNTech to lead $2 billion mRNA-based oncology therapy market despite challenges, says GlobalData
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Health Assurance is a unique healthcare model that combines health insurance with preventive healthcare with a focus on keeping people healthy while providing sick care for them when needed
Sets price band at ?695 to ?735 per Equity Share
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
The approval bolsters the company's Mycophenolate Mofetil portfolio
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
Subscribe To Our Newsletter & Stay Updated
